BMC Genomics by Liu, Shiyou et al.
RESEARCH ARTICLE Open Access
Evolution of mitosome metabolism and
invasion-related proteins in Cryptosporidium
Shiyou Liu1,2, Dawn M. Roellig2, Yaqiong Guo1,2, Na Li1,2, Michael A. Frace3, Kevin Tang3, Longxian Zhang4,
Yaoyu Feng1* and Lihua Xiao2*
Abstract
Background: The switch from photosynthetic or predatory to parasitic life strategies by apicomplexans is accompanied
with a reductive evolution of genomes and losses of metabolic capabilities. Cryptosporidium is an extreme
example of reductive evolution among apicomplexans, with losses of both the mitosome genome and many
metabolic pathways. Previous observations on reductive evolution were largely based on comparative studies
of various groups of apicomplexans. In this study, we sequenced two divergent Cryptosporidium species and
conducted a comparative genomic analysis to infer the reductive evolution of metabolic pathways and
differential evolution of invasion-related proteins within the Cryptosporidium lineage.
Results: In energy metabolism, Cryptosporidium species differ from each other mostly in mitosome metabolic
pathways. Compared with C. parvum and C. hominis, C. andersoni possesses more aerobic metabolism and a
conventional electron transport chain, whereas C. ubiquitum has further reductions in ubiquinone and polyisprenoid
biosynthesis and has lost both the conventional and alternative electron transport systems. For invasion-associated
proteins, similar to C. hominis, a reduction in the number of genes encoding secreted MEDLE and insulinase-like
proteins in the subtelomeric regions of chromosomes 5 and 6 was also observed in C. ubiquitum and C. andersoni,
whereas mucin-type glycoproteins are highly divergent between the gastric C. andersoni and intestinal Cryptosporidium
species.
Conclusions: Results of the study suggest that rapidly evolving mitosome metabolism and secreted invasion-related
proteins could be involved in tissue tropism and host specificity in Cryptosporidium spp. The finding of progressive
reduction in mitosome metabolism among Cryptosporidium species improves our knowledge of organelle evolution
within apicomplexans.
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Background
The evolution of life generally proceeds towards bigger
genomes and increased complexity, as the organisms
adapt to new niches and environment. Recent evolutio-
nary reconstructions, however, have shown a common
occurrence of genome reduction, especially in parasitic
and symbiotic organisms [1]. Among alveolates, a group
of unicelluar eukaryotes consisted of photosynthetic
protozoa, free-living predators, and obligate intracellular
parasitic protozoa, reductive evolution is often observed
in parasitic apicomplexans. For example, compared with
the closely related chromerids, the photosynthetic algae, a
significant reduction in genome sizes has occurred in api-
complexans [2]. Among apicomplexans, Cryptosporidium
spp. and gregarines have lost the apicoplast, a plastid with-
out photosynthetic functions, and depend on host cells for
basic nutrients [3–6]. It is generally accepted that Crypto-
sporidium spp. as the based branch of Apicomplexa have
also lost many other metabolic capabilities during the
reductive evolution, especially the mitochondria-like
organelle-derived energy metabolism, such as the tricarb-
oxylic acid (TCA) cycle and cytochrome-based electron
transport chain [4, 5, 7]. Cryptosporidium muris, however,
* Correspondence: yyfeng@ecust.edu.cn; lxiao@cdc.gov
1State Key Laboratory of Bioreactor Engineering, School of Resources and
Environmental Engineering, East China University of Science and Technology,
Shanghai 200237, China
2Division of Foodborne, Waterborne, and Environmental Diseases, Centers for
Disease Control and Prevention, Atlanta, GA 30329, USA
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Liu et al. BMC Genomics  (2016) 17:1006 
DOI 10.1186/s12864-016-3343-5
has been shown recently to have all enzymes associated
with the TCA cycle and a conventional respiratory chain
system [8].
Cryptosporidium spp. are major causes of diarrhea in
human and other animals, is [9]. To date, about 30
Cryptosporidium species have been recognized in
humans, livestock, companion animals, and wild verte-
brates [10]. They differ from each other in host specifi-
city and predilection sites [10]. Among them, C. parvum
and C. hominis are intestinal species and common
causes of human cryptosporidiosis [11]. Although C.
hominis is largely a pathogen of humans and nonhuman
primates, C. parvum is also a major pathogen in rumi-
nants. Recently, another intestinal Cryptosporidium
species, C. ubiquitum, has been detected in humans in
industrialized nations [12, 13]. Like C. parvum, this
species has a broad host range and can infect other
primates, domestic and wild ruminants, and rodents
[12, 13]. In contrast, C. andersoni is a gastric species
in cattle and has only been detected occasionally in
other animal species [10, 14]. It is genetically related
to another gastric species, C. muris, which infects a
broad range of mammals and occasionally birds [15].
Like C. hominis, most other recognized Cryptosporid-
ium species have some host specificity [10].
The genomes of C. parvum [5] and C. hominis [4]
were sequenced using the Sanger technology and pub-
lished in 2004. C. muris was also sequenced subse-
quently and its genome has been available in GenBank
and CryptoDB (release 3.5) since 2007. All Cryptosporid-
ium genomes presumably have 8 chromosomes, are
around 9 Mb in size, and are more compact and efficient
than genomes of most other apicomplexans [4, 5]. The
predicted proteomes are highly similar between the two
intestinal species C. parvum and C. hominis. However, a
preliminary analysis of the C. muris genomic data has
shown significant divergence in mitosome carbon and
energy metabolism [8]. Because of the overall nucleotide
sequence divergence between the C. parvum and C.
hominis genomes is just ~3%, it has been suggested that
differences in phenotypic characteristics between the
two species, such as host range [11] and host cell
invasion [16], may be caused by subtle sequence vari-
ations in coding regions or differences in expression
levels of key genes rather than genome rearrange-
ments and structural alterations [17]. Recently, several
major insertions and deletions in gene content have
been identified between the two closely related intes-
tinal species, and it was suggested that subtelomeric
gene duplications and deletions in two secreted protein
families (MEDLE and insulinase-like proteins) in chromo-
somes 5 and 6 could be responsible for some of the
observed biologic differences between C. parvum and C.
hominis [18].
Although the first two genomes of Cryptosporidium
spp. were sequenced over a decade ago, studies on gen-
ome evolution within the Cryptosporidium lineage is prac-
tically non-existent. As a result, we still have very limited
knowledge of the evolution and invasion of Cryptosporid-
ium spp. This is largely the result of only a limited number
of Cryptosporidium species sequenced at the whole
genome level. Here, we sequenced the genomes of six C.
ubiquitum and C. andersoni isolates and conducted a
comparative genomic analysis of Cryptosporidium spp.
and other well-studied apicomplexans. We focused on
reductive evolution in energy metabolism and differential
evolution of invasion-related proteins among Cryptospor-
idium species, as they may be involved in tissue tropism
and host specificity.
Results
Genome reduction in Cryptosporidium
The genomes of three isolates each of C. ubiquitum and
C. andersoni were sequenced. The best assembly was
8.97 Mb in 27 contigs for C. ubiquitum and 9.10 Mb in
96 contigs for C. andersoni (Additional file 1: Table S1).
Genomes of all Cryptosporidium spp. have similar struc-
tural features, including genome size, GC content, num-
ber of tRNA genes, codon usages, and over-represented
DNA sequence motifs in upstream regions of protein-
coding genes (Table 1 and Additional file 2: Figure S1).
Gene organization of chromosomes is in almost complete
synteny and sequences identity is higher between the
genomes of C. ubiquitum and C. parvum. In contrast, the
genome sequence of C. andersoni is very different from
that of C. parvum (Additional file 3: Figure S2A).
Altogether, 3767 and 3905 protein-coding genes were
identified in the C. ubiquitum and C. andersoni genomes,
respectively (Table 1).
The Cryptosporidium species under analysis share a
large group of orthologs, with only a small number of
species-specific genes. As expected, the number of
species-specific genes in C. andersoni is apparently big-
ger than that among intestinal species (Additional file 3:
Figure S2B). The divergent nature of C. andersoni is sup-
ported by phylogenetic analysis of 100 orthologs from
Cryptosporidium spp. and other common apicomplexan
parasites (Fig. 1a). All Cryptosporidium species have
similar numbers and components of major protein
families, except for C. andersoni, which has fewer genes
encoding insulinase-like peptidases (Fig. 1b).
The metabolic capabilities of the four Cryptosporidium
spp. are dramatically reduced compared with P. falcip-
arum and T. gondii. This is especially reflected in carbohy-
drate, amino acid, and energy metabolism, with a limited
de novo biosynthesis and overall reliance on the hosts for
basic nutrients by Cryptosporidium spp. (Table 2). Other
reductive evolutionary features in Cryptosporidium spp.
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include reduced gene numbers and length and increased
gene density (Table 1), which were previously observed in
C. parvum and C. hominis genomes [4, 5]. As expected,
no apicoplast and mitochondrial genomes were detected
in any Cryptosporidium species.
Divergent mitosome metabolism among Cryptosporidium
spp.
Compared with the canonical aerobic mitochondrion in
most eukaryotic organisms, the mitosome of Cryptospor-
idium spp. has undergone remarkable reduction in size
and function probably because of the anaerobic environ-
ment in the digestive tract [19]. The comparative analysis
of metabolism of C. ubiquitum, C. andersoni and other
Cryptosporidium spp. shows that mitosome metabolism,
including the electron transport chain, has gone through
progressive reductions within the Cryptosporidium genus
(Fig. 2).
TCA cycle and related metabolism in C. andersoni
Unlike intestinal Cryptosporidium spp., C. andersoni
possesses a complete set of enzymes involved in the
TCA cycle and related metabolism, such as the substrate
transport system and salvage of the cofactor lipoic acid
(Table 2, Fig. 2). In Plasmodium falciparum and
Toxoplasma gondii, pyruvate derived from glycolysis is
oxidated into acetyl-CoA by a multi-protein enzyme in
the apicoplast, pyruvate dehydrogenase complex (PDH)
[6]. Cryptosporidium spp. do not have this complex, but
possess an alternative pyruvate:NADP+ oxidoreductase
(PNO) localized in the cytosol [20]. The product, acetyl-
CoA presumably is delivered into mitosomes through
the transporter protein embedded on the mitosome
membrane in C. andersoni. In other Cryptosporidium
spp., acetyl-CoA is primarily involved in metabolic path-
ways in the cytosol, such as type I fatty acid biosynthesis,
although this pathway was also detected in C. andersoni.
The oxoglutarate dehydrogenase complex (OGDH) from
the TCA cycle can become active when it couples with
two cofactors, thiamine pyrophosphate (TPP) and lipoic
acid. Among apicomplexans, only P. falciparum has the
ability to synthesize thiamine de novo [21]. C. andersoni
has to salvage TPP directly from the host, although its
transporter has not been identified. In addition to
synthesizing lipoic acid de novo in the apicoplast, P. f-
alciparum and T. gondii can salvage lipoic acid from the
host into the mitochondrion and conjugate it onto
OGDH through the lipoate-protein ligase [22]. The gene
encoding this ligase is present in the C. andersoni
genome, indicating that C. andersoni salvages host lipoic
acid and utilizes it presumably in mitosomes. Unlike T.
gondii, which possesses de novo biosynthesis of CoA, all
Cryptosporidium spp. salvage pantothenate from host
cells and convert it into CoA.
Absence of polyisoprenoid biosynthesis in C. ubiquitum
In T. gondii, two 5-carbon isoprene units, isopentenyl di-
phosphate (IPP) and dimethylallyl diphosphate (DMAPP),
Table 1 Genomic features of Cryptosporidium ubiquitum and C. andersoni in comparison with other apicomplexan parasitesa
P. falciparum T. gondii C. parvum C. hominis C. ubiquitum C. andersoni
Total length (Mb) 22.85 65.67 9.10 8.74 8.97 9.09
No. of super contigs 16 2,263 8 1,422 27 135
GC content (%) 20.0 48.5 30.3 30.9 30.8 28.5
No. of genes 5,542 8,322 3,805 3,886 3,767 3,905
Total length of CDS (Mb)b 12.58 20.03 6.83 5.28 6.94 6.86
GC content in CDS (%) 25.0 56.0 31.9 32.7 33.0 30.1
GC content at 3rd position in codons (%) 18.0 59.0 18.0 19.0 20.0 14.0
Mean length of genes (bp) 2,271 2,407 1,720 1,360 1,841 1,757
Gene density (gene/Mb) 242.5 126.7 418.1 444.6 420.0 429.6
Percent coding (%) 55.1 30.5 75.0 60.4 77.4 75.5
No. of genes with intron 3,055 6,729 163 8 758 832
Genes with intron (%) 55.1 80.9 4.2 0.02c 20.1 21.3
No. of tRNA 72 174 45 46 45 44
No. of tRNAmet 2 8 2 2 2 2
Proteins with signal peptide 638 759 397 421 399 309
Proteins with transmembrane domain 1,754 1,103 832 769 772 839
Proteins with GPI anchor 62 255 63 51 50 47
aSource of data: Plasmodium falciparum: PlasmoDB release-11.1; Toxoplasma gondii: ToxoDB release-11.0; C. parvum and C. hominis: CryptoDB release-6.0
bCoding regions excluding intron sequences
cEstimated to be 5–20% by Xu et al., [4]
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are synthesized de novo in the apicoplast from glycolysis-
derived phosphonel pyruvate and dihydroxyacetone phos-
phate through the chloroplast-type MEP/DOXP pathway
[6]. Both IPP and DMAPP are transported into the mito-
chondrion and condensed into farnesyl diphosphate (FPP)
and polyprenyl diphosphate (PPP) [21, 23]. All Cryptospor-
idium spp. lack not only the apicoplast but also the genes
coding enzymes for de novo isoprenoid biosynthesis
(Table 2, Fig. 2). Within the subsequent mitosome poly-
isoprenoid anabolic pathway, two essential enzymes,
FPP synthase and polyprenyl synthase, are absent in
the predicted proteome of C. ubiquitum but present
in other Cryptosporidium spp. The genes (cgd4_2550,
cgd7_3730) encoding these two enzymes were shown
transcribed in C. parvum in vitro, especially during
early (2–6 h) infection [24]. Artz et al. suggested that
the enzyme encoded by cgd4_2550 is a non-specific
polyprenyl pyrophosphate synthase rather than FPP syn-
thase only [25]. These two enzymes may cooperatively
synthesize pyrophosphoric polyisoprenoids in C. parvum.
As PPP is an essential substrate for the biosynthesis of
ubiquinone, the absence of polyisprenoid biosynthesis in
C. ubiquitum is consistent with its loss of ubiquinone bio-
synthesis (see below). In addition to participating in the
biosynthesis of ubiquinone, isoprenoids such as FPP and
PPP are involved in signaling pathways, post-translational
modifications of proteins, and isoprenylation of tRNAs
[6]. C. ubiquitum possesses enzymes involved in the iso-
prenylation of both proteins and tRNAs, suggesting that it
may salvage FPP and PPP in addition to IPP and DMAPP
from the host.
The absence in C. ubiquitum of three mitosome carrier
proteins possessed by C. parvum further demonstrates
that mitosome metabolic capabilities in C. ubiquitum
are more limited than those of other Cryptosporidium
spp. (Table 3). Because of the existence of more
metabolic pathways within mitosomes, C. andersoni
has several more mitosome transporter proteins than
other Cryptosporidium spp. In addition, C. andersoni
possesses two more amino acid transporters and one




Fig. 1 Genomic features and phylogenetic relationship of Cryptosporidium spp. a Phylogenetic relationship between Cryptosporidium spp. and
other common apicomplexan parasites based on neighbor-joining analysis of sequences of 100 shared proteins. A concatenated sequences from
the free-living photosynthetic chromerid, Chromera velia, was used to root the tree. b Comparison of major invasion-related protein families
among Cryptosporidium species. The number of each protein family was identified based on Pfam domain search only, which may differs from
the result of ortholog comparisons. Abbreviation of Cryptosporidium spp.: Cpar: Cryptosporidium parvum; Chom: C. hominis; Cubi: C. ubiquitum;
Cand: C. andersoni
Liu et al. BMC Genomics  (2016) 17:1006 Page 4 of 16
Table 2 Comparison of essential metabolic pathways among Cryptosporidium spp. and other common apicomplexan parasitesa
Category Metabolic pathway Cpar Chom Cubi Cand Pfal Tgon
Carbohydrate and energy
metabolism
Glycolysis + + + + + +
Methylcitrate cycle - - - - - +
TCA cycle - - - + + +
Pentose phosphate pathway - - - - + +
Shikimate biosynthesis - - - - + +
Folate biosynthesis - - - - + +
Synthesis of tetrahydrobiopterin/dihydrobiopterin/
molybdopterin
- - - - - +
Galactose metabolism - - - - - +
Synthesis of starch + + + + - +
Synthesis of trehalose + + + + - +
Synthesis of 1,3-beta-glucan - - - - - +
UDP-Glc < - > UDP-Gal + + + + - +
GDP-Man < - > GDP-Fuc - - - - + +
UDP-Glc - > UDP-GlcA - > UDP-Xyl + + + + - -
Synthesis of mannitol from fructose + + + + - -
Fatty acid biosynthesis in cytosol (FAS I) + + + + - +
Fatty acid biosynthesis in apicoplast (FAS II) - - - - + +
Fatty acid degradation - - - - - +
Oxidative phosphorylation (NADH dehydrogenase) + + + + + +
Oxidative phosphorylation (Complex II) - - - + + +
Oxidative phosphorylation (Complex III) - - - 1 subunit + +
Oxidative phosphorylation (Complex IV) - - - - + +
F-ATPase 2 subunit 2 subunit 2 subunit + + +
Alternative oxidase (AOX) + + + + - -
Glyoxalase metabolism producing D-lactate - - - - + +
Synthesis of isoprene (MEP/DOXP) - - - - + +
Synthesis of farnesyl/polyprenyl diphosphate + + - + + +
Nucleotide metabolism Synthesis of purine rings de novo - - - - - -
IMP - > XMP - > GMP + + + - + +
Synthesis of pyrimidine de novo - - - - + +
Amino acid metabolism Synthesis of alanine from pyruvate - - - - - +
Synthesis of glutamate from nitrite/nitrate - - - - + +
Conversion from glutamate to glutamine + + + + + +
Synthesis of aspartate from oxaloacetate and glutamate - - - - + +
Conversion from aspartate to asparagine + + + - + +
Conversion from glutamate to proline + + + + - +
Synthesis of serine from glycerate/glycerol phosphate - - - - - +
Conversion from serine to cysteine - - - - - +
Conversion from serine to glycine + + + + + +
Recycle homocysteine into methionine - - - - + +
Synthesis of lysine from aspartate - - - - - +
Synthesis of threonine from aspartate - - - - - +
Synthesis of ornithine from arginine - - - - + -
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Progressive reduction in electron transport chain in
Cryptosporidium spp.
Within the oxidative phosphorylation pathway on the
inner mitochondrial membrane, the classical NADH
dehydrogenase multi-protein complex, named complex
I, is substituted by an alternative single NADH dehydro-
genase in most apicomplexan parasites [21]. Similar to
P. falciparum and T. gondii, which use three other
multi-protein complexes (II-IV) to transfer electrons to
oxygen, C. andersoni has the complete complex II, suc-
cinate dehydrogenase, which is also involved in the TCA
cycle, and one subunit of complex III, ubiquinol-
cytochrome c oxidoreductase. In contrast, C. parvum, C.
hominis, and C. ubiquitum have lost these enzyme com-
plexes entirely (Table 2, Fig. 2). With electrons trans-
ported through the chain, a proton gradient is generated
across the inner mitochondrial membrane and the
energy generated can be used to produce ATP by the
ATP synthase (also known as complex V). Similar to P.
falciparum and T. gondii, C. andersoni possesses a
complete F-type ATP synthase, but only two subunits
(subunit α and β) of this enzyme are present in C.
parvum, C. hominis and C. ubiquitum.
Ubiquinone, also known as coenzyme Q, is responsible
for transferring electrons from complex I or complex II
to complex III. It is synthesized from chorismate, which
has to be salvaged from the host because of the absence
of the shikimate pathway in Cryptosporidium spp.,
together with two other substrates polyisoprenoid and
adenosyl methionine [21]. C. parvum, C. hominis, and C.
andersoni possess all enzymes and proteins involved in
the ubiquinone biosynthesis [21]. Most of these enzymes
have experimental expression evidence in C. parvum
and show a higher expression level at the end (36–72 h)
of the in vitro infection [24]. The absence of five add-
itional enzymes suggests that C. ubiquitum lacks the
capability of ubiquinone biosynthesis (Table 2, Fig. 2).
In addition to the conventional mitochondrial electron
transport system, there is also a cytochrome-independent
system executed by a cyanide-insensitive alternative oxi-
dase (AOX), passing electrons from ubiquinone directly
to oxygen to form water in higher plants, fungi and several
protozoa [26–28]. All Cryptosporidium spp. possess
orthologs of AOX [4, 5], with the exception of C. ubiqui-
tum. This alternative pathway does not couple the proton
transport across the inner mitosome membrane, indicat-
ing that energy production is reduced in intestinal Crypto-
sporidium spp. AOX in C. parvum can be inhibited by
salicylhydroxamic acid and 8-hydroxyquinoline, affecting
the growth of the parasite [27]. The mammalian
Table 2 Comparison of essential metabolic pathways among Cryptosporidium spp. and other common apicomplexan parasitesa
(Continued)
Synthesis of ornithine from proline - - - - + +
Synthesis of polyamine from ornithine - - - - + -
Polyamine pathway backward + + + + - +
Degradation of branch-chain amino acids - - - - - +
Synthesis of tryptophan + + + - - -
Aromatic amino acid hydroxylases (AAAH) - - - - - +
Vitamin and others Synthesis of ubiquinone (Coenzyme Q) + + - + + +
Synthesis of Fe-S cluster + + + + + +
Synthesis of heme - - - - + +
Synthesis of thiamine (Vitamin B1) - - - - + -
Conversion from thiamine to thiamine pyrophosphate
(TPP)
- - - - + +
Synthesis of FMN/FAD from riboflavin - - - - + +
Synthesis of pyridoxal phosphate (Vitamin B6) de novo - - - - + +
Synthesis of NAD(P) + de novo from nicotinate/
nicotinamide
- - - - + +
Synthesis of pantothenate from valine - - - - - +
Synthesis of CoA from pantothenate + + + + + +
Synthesis of lipoic acid de novo in apicoplast - - - - + +
Salvage of lipoic acid in mitochondria - - - + + +
Synthesis of porphyrin/cytochrome proteins - - - - + +
aPlus symbol denotes that the essential enzymes for the pathway were identified, whereas minus symbol denotes that the essential enzymes for pathways
were absent
Cpar Cryptosporidium parvum, Chom C. hominis, Cubi C. ubiquitum, Cand C. andersoni, Pfal Plasmodium falciparum Pfal, Tgon Toxoplasma gondii
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bloodstream form of Trypanosoma brucei depends en-
tirely on the AOX pathway for electron transport, making
AOX an attractive target for drug development [29, 30].
The absence of AOX in C. ubiquitum suggests that the
electron transport chain is totally lost in this apicom-
plexan parasite (Table 2, Fig. 2).
Unexpectedly, the gene encoding malate:quinone
oxidoreductase (MQO), the enzyme involved in both the
TCA cycle and electron transport chain, is present in
most apicomplexans including C. parvum, C. hominis
and C. ubiquitum (Fig. 2). MQO was presumably gained
by the ancestors of apicomplexans, chromerids, and dino-
flagellates from bacteria though lateral gene transfer [8].
Reductive evolution in biosynthesis of N-glycan and
GPI-anchor precursors in Cryptosporidium spp.
Asparagine (N)-linked glycosylation is a common post-
translational modification of proteins and the biosyn-
thesis of N-glycans has been shown to be different among
apicomplexan parasites [31]. Due to the secondary loss of
Alg genes, apicomplexans differ from each other in the
length of N-glycan precursors; the length of oligosacchar-
ide chain of N-glycan precursors in Cryptosporidium spp.
is shorter than that in T. gondii but longer than in P. fal-
ciparum (Fig. 3a). Among Cryptosporidium spp., intestinal
species C. parvum, C. hominis and C. ubiquitum possess
nine sugars in N-glycan precursors, whereas the gastric
species C. andersoni has only five sugars. The addition of
two mannose molecules and two glucose molecules onto
the core structure of N-glycan precursor is lost in C.
andersoni.
A large number of surface proteins attach to the cell
membrane via the glycosylphosphatidylinositol (GPI)
anchor [32]. The construction of GPI-anchors occurs in
three stages: i) biosynthesis of a GPI precursor in the
endoplasmic reticulum (ER) membrane, ii) attachment
of the GPI to the C-terminus of a newly synthesized pro-
tein in the ER lumen, and iii) lipid remodeling and/or
carbohydrate side-chain modifications in ER and Golgi
lumens. The critical mannosyltransferase (PIG-B) cata-
lyzing the addition of the third and fourth mannose onto
the GPI-anchor precursor located in the ER lumen is
present in C. parvum, C. hominis and C. andersoni but
absent in C. ubiquitum (Fig. 3b). The transcription of
the PIG-B encoding gene (cgd3_3590) has been demon-
strated in C. parvum, with a high level of expression at
Fig. 2 Reductive evolution in mitosome metabolism among Cryptosporidium spp. in comparison with Toxoplasma gondii. Abbreviation of
enzymes: AOX: alternative oxidase; PDH: pyruvate dehydrogenase complex; PNO: pyruvate:NADP(+) oxidoreductase; MAT: methionine adenosyl
transferase; OGDH: oxoglutarate dehydrogenase complex; MQO: malate:quinone oxidoreductase; BCKDH: branched-chain ketoacid dehydrogenase
complex. Abbreviation of metabolites: Q: ubiquinone (coenzyme Q); CoA: coenzyme A; IPP: isopentenyl diphosphate; DMAPP: dimethylallyl
diphosphate; FPP: farnesyl diphosphate; PPP: polyprenyl diphosphate; MC: 2-methylcitrate; TCA: tricarboxylic acid; TPP: thiamine pyrophosphate.
Abbreviation of transporter proteins: APT1: apicoplast phosphate translocator; CTP: CoA transporter protein; ACTP: acetyl-CoA transporter protein;
OMTP: oxoglutarate/malate transporter protein
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the end of in vitro infection [24]. In addition, unlike in
other apicomplexan parasites, the acylation (mediated by
PIG-W) and de-acylation (mediated by PGAP1) of inosi-
tol during the construction of GPI-anchor precursors in
the ER lumen are absent in all Cryptosporidium spp.
Reductive evolutions in other metabolic pathways
The gene encoding tryptophan synthase (cgd5_4560)
catalyzing biosynthesis of tryptophan from serine and
indole was identified in intestinal Cryptosporidium spp.
but not in the gastric species C. andersoni. It has been
suggested that intestinal bacteria can provide indole to
C. parvum and C. hominis whereas this bacterial com-
munity does not exist in the stomach of the host, leading
to the absence of tryptophan biosynthesis in gastric
Cryptosporidium spp. [21]. Similarly, the gene encoding
asparagine synthase A (AsnA) (cgd5_4540), which
converts aspartate into asparagine, is only absent in
C. andersoni.
All apicomplexan parasites are unable to synthesize
purine rings de novo and have to salvage them from the
host. Only one purine nucleotide transporter was detected
in Cryptosporidium spp. and it probably transports adeno-
sine only [21]. C. parvum, C. hominis and C. ubiquitum
convert AMP into GMP through IMP dehydrogenase
(cgd6_20) and GMP synthase (cgd5_4520), which have
not been identified in C. andersoni.
Differential evolution in invasion-related proteins
Apicomplexan parasites possess several unique secretory
organelles such as the rhoptry, microneme, and dense
granules, which secret various catalytic proteins for host
cell adhesion and invasion [33]. Among secreted pro-
teins of Cryptosporidium spp., two protein families,
mucin-type glycoproteins and thrombospondin-related
adhesive proteins (TRAPs), are considered essential to
host cell attachment [34, 35]. The genes encoding
mucin-type glycoproteins associated with adhesion, such
as gp900, gp60/40/15, P23, P30, CP2, and Clec, were
compared among the four Cryptosporidium species and
results of the comparison have shown a high divergence
of C. andersoni from other species in compositions of
these genes (Fig. 4 and Additional file 4: Table S2). In C.
parvum, the gp60/40/15 complex, which is absent in C.
andersoni, is probably translated from one single mRNA,
glycosylated, and proteolytically processed into two
smaller glycoproteins. The latter are localized at the sur-
face or apical region of the parasite and thought to be
involved in attachment and invasion [34]. P23, a surface
protein that induces antibody responses in animal hosts,
Table 3 Putative transporters in Cryptosporidium spp. and other common apicomplexan parasitesa
Substrates Cellular location Cpar Chom Cubi Cand Pfal Tgon
Hexose 2 2 2 2 2 5
Triose phosphate Plasma/Apicoplast membrane 8 5 8 8 4 4
Amino acids Plasma membrane 10 10 10 12 1 6
Nucleobase/nucleoside Plasma membrane 1 1 1 1 4 4
Nucleotide-sugar Plasma membrane 3 3 3 2 1 4
Folate/pterine Plasma membrane 1 1 1 1 2 7
Formate/nitrite 0 0 0 0 1 3
GABA (aminobutanoate) Plasma/Mitochondrial membrane 0 0 0 0 2 5
Acetyl-CoA 1 0 1 1 1 1
Chloride 0 0 0 0 0 2
Inorganic phosphate 0 0 0 0 1 1
Sulfate 1 1 1 1 1 4
Sodium/potassium/calcium 2 2 2 3 0 9
Zinc 2 2 2 2 2 4
Copper 1 1 1 1 2 3
Choline Plasma membrane 0 0 0 0 1 2
Cadmium/zinc/cobalt (efflux) Plasma membrane 1 1 1 1 1 1
Glycerol/water Plasma membrane 0 0 0 0 2 2
ABC transporterb Plasma membrane 21 18 21 21 16 24
Mitochondrial carrierb Mitochondrial membrane 9 7 6 13 14 21
aThe detection of these transporter proteins was based on the Pfam search results
bABC transporters and mitochondrial carriers have a broad range of substrates
Cpar Cryptosporidium parvum, Chom C. hominis, Cubi C. ubiquitum, Cand C. andersoni, Pfal Plasmodium falciparum Pfal, Tgon Toxoplasma gondii
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is absent in C. andersoni but present in other Crypto-
sporidium spp. [34]. CP2, the membrane associated
protein that is also absent in C. andersoni, has been
shown to be localized in the parasitophorous vacuole
membrane (PVM) and is probably involved in host cell
invasion or PVM integrity [36]. In addition, seven small
mucin genes (muc1-7) located in tandem in chromo-
some 2 of C. parvum are expressed during intracellular
development and products of at least two of them,
Muc4 and Muc5, are associated with host cell attachment
and invasion [37]. Among them, Muc6 is absent in C. ubi-
quitum and none of them are present in C. andersoni. A
major characteristic of these mucin proteins is their low
similarity in amino acid sequences. Among the species-
specific proteins, 5 and 30 are O-linked mucin-type glyco-
proteins in C. ubiquitum and C. andersoni, respectively
(Additional file 5: Table S3). Some of them are probably
responsible for host specificity in Cryptosporidium spp. In
addition to host cell attachment, mucin-type glycoproteins
may contribute to the tethering of sporozoites to the inner
surface of the oocyst walls [38].
TRAPs, the best-characterized microneme proteins for
gliding motility and host cell invasion in apicomplexans,
usually contain two types of adhesive domains: the von
Willebrand factor type A (VWA) domain and thrombos-
pondin 1 (TSP1) domain, such as the TRAP of P. falcip-
arum and MIC2 of T. gondii [39]. A screening of the
TSP1 domain revealed that C. parvum possesses 12
paralogous genes (CpTSP1-12), which all have putative
signal peptides and one or more TSP1 domains [40].
There are no VWA domains but other modules such as
Kringle and epidermal growth factor (EGF) were de-
tected within these TRAP genes. CpTSP8, previously
known as CpMIC1 containing three TSP1 repeats and
one EGF domain, is translocated to the surface of the
parasite together with other microneme proteins [41].
All of these TRAP genes are present in the C. ubiquitum
and C. andersoni genomes with the exception of TSP11,
which is located in chromosome 6 and highly expressed
in both early and late stages of C. parvum infection [40],
is absent in C. ubiquitum (Fig. 4 and Additional file 4:
Table S2).
Fig. 3 Diversity in post-translational modifications of proteins among Cryptosporidium spp. A) Divergent N-glycan precursors in different
Cryptosporidium spp. and other apicomplexan parasites. B) Core structure of GPI-anchor and the critical enzymes involved in its biosynthesis. PIG-B is
absent in Cryptosporidium ubiquitum but present in other Cryptosporidium spp., whereas PIG-W and PGAP1 are absent in all Cryptosporidium spp.
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A variety of secreted proteases and protein kinases in
secretory organelles of apicomplexans are involved in
processing invasion-related proteins or modifying host
cell activities, enabling the evasion of host immune sys-
tem during invasion [42]. Two members of the
insulinase-like proteases containing the peptidase family
M16 domain located in the subtelomeric region of
chromosome 6 of C. parvum have been shown to be
lost in the C. hominis genome. This is one of the few
differences in gene content between these two closely
related species with different host specificity [18]. In
addition to the absences of these two subtelomeric
genes on chromosome 6, one member (the ortholog
of cgd3_4270, which has 90% nucleotide sequence
similarity to cgd3_4260) of another insulinase gene
cluster in the subtelomeric region of chromosome 3
of C. parvum is absent in C. ubiquitum. Additional
paucity of this gene family was seen in C. andersoni,
especially in genes located in subtelomeric regions.
No new insulinase-like genes were identified in C.
ubiquitum, although C. andersoni appears to have
two or three new ones (Fig. 4 and Additional file 4:
Table S2).
Another major genetic difference between genomes of
C. parvum and C. hominis is in the number of genes
encoding the MEDLE family surface proteins in the 3′
subtelomeric regions of chromosomes 5 and 6. Five of
the six MEDLE family protein genes in C. parvum have
no orthologs in C. hominis [18]. The two subtelomeric
regions are both absent in genomes of C. ubiquitum and
C. andersoni (Fig. 4 and Additional file 4: Table S2). Al-
though the specific functions of these proteins have not
been determined, most of them have a signal peptide.
Rhomboids, a family of intra-membrane serine prote-
ases, are ubiquitously present in apicomplexan parasites
and responsible for the cleavage of secreted adhesive
proteins [43]. One additional rhomboid gene was detected
in the genome of C. andersoni compared with other
Cryptosporidium spp. (Additional file 4: Table S2).
Discussion
Whole genome sequencing and comparative genomic
analysis have revealed a progressive reduction of mito-
some metabolism in the genus Cryptosporidium, including
major energy production mechanism, the electron trans-
port chain, and the associated ancillary pathways. As
Fig. 4 Diversity in invasion-related secreted protein and peptidase families among Cryptosporidium species. Abbreviation of Cryptosporidium spp.:
cp: Cryptosporidium parvum; ch: C. hominis; cu: C. ubiquitum; ca: C. andersoni. The species name in red represents the absence of this
family member
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shown in this study, like the genetically related C. muris
[8], C. andersoni uses both the TCA cycle and glycolysis
for energy metabolism and has a near conventional oxida-
tive phosphorylation system. In contrast, C. parvum and
C. hominis do not have the TCA cycle and possess an
alternative oxidative phosphorylation chain, whereas C.
ubiquitum has further lost the entire electron transport
chain and the associated biosynthesis of ubiquinone and
polyisoprenoids. It has been shown that Cryptosporidium
spp. and gregarines differ from other apicomplexans in
energy metabolism because of the absence of the intracel-
lular organelle apicoplast and the presence of an alterna-
tive electron transport system. Data from this study now
show a progressive reductive evolution in energy metabol-
ism within the Cryptosporidium/gregarine lineage of api-
complexans. Thus far, energy metabolism and electron
transport chain appear remarkably conserved in other
lineages of apicomplexans (Fig. 5).
It is generally accepted that the ancestor of apicom-
plexan parasites obtained the mitochondrion and apico-
plast through primary and secondary endosymbiosis,
respectively [22]. During the reductive evolution process,
most of the organelle metabolism-related genes have
been progressively lost or horizontally transferred to
nuclear genomes as different lineages adjust to new life
strategies that differ from the photosynthetic or free-
living lifestyle [2, 7]. Cryptosporidium spp. represent the
extreme of apicomplexans, with the total loss of the api-
coplast and having only a mitochondrial replica without
the associated genome. The progressive losses of energy
generation pathways and electron transport chains in
Cryptosporidium spp. are probably results of adaptation
to different niches of parasitism. As gregarines have
retained several common features, such as the presence
of a TCA cycle and a conventional electron transport
chain, they probably represent ancestry members of the
Cryptosporidium/gregarine lineage. Within the Crypto-
sporidium genus, C. andersoni appears to be an earlier
member of the genus Cryptosporidium, whereas C. ubi-
quitum is probably a recent one (Fig. 5). Studies with
molecular clocks are needed to confirm this theory.
The loss of enzymes involved in the biosynthesis of
ubiquinone and polyisoprenoids in C. ubiquitum supports
the conclusion on progressive evolution of energy metab-
olism and electron transport systems in the Cryptosporid-
ium/gregarine lineage. Accompanying the loss of the
conventional and alternative electron transport systems,
C. ubiquitum has lost the ability to synthesize polyisopre-
noids, which are substrates in ubiquinone biosynthesis,
and ubiquinone itself, which is part of the conventional
electron transport chain. By inspection of Mauve genome
alignments, most of the genes that are absent in C. ubiqui-
tum but present in C. parvum and C. hominis have syn-
tenic nucleotide sequences in the C. ubiquitum genome,
Fig. 5 Reductive evolution of organelle-derived metabolism among major apicomplexan lineages. Abbreviation: AOX: alternative oxidase; FPP:
farnesyl diphosphate; PPP: polyprenyl diphosphate; CoQ: coenzyme Q; TCA: tricarboxylic acid; LA: lipoic acid; BCAA: branched-chain amino acid;
PDH: pyruvate dehydrogenase complex; FAS: fatty acid synthase
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suggesting the occurrence of secondary losses of these
functional genes in C. ubiquitum during species evolution.
In agreement with this, C. andersoni, which has a TCA
cycle, possesses several transporters for TCA substrates
(such as acetyl CoA, oxoglutarate malate, and OGDH),
more mitosome carrier proteins, and a salvage system for
the cofactor lipoic acid. C. ubiquitum probably needs to
salvage isoprenoids from the host for tRNA isoprenylation
via enzyme miaA, which together with its downstream en-
zyme, miaB, is present in all Cryptosporidium genomes.
Because isoprenylation of tRNA in apicomplexans occur
mostly in the apicoplast [6], the ancestor of Cryptosporid-
ium spp. probably had an apicoplast.
Reductive evolution apparently occurs in other metab-
olism processes in Cryptosporidium spp. Highly diver-
gent N-glycan precursors have been seen among protists
due to the secondary loss of Alg genes during reductive
evolution [31]. Within the Cryptosporidium genus, the
N-glycan precursor of the gastric C. andersoni has four
fewer oligosaccharides than intestinal Cryptosporidium
spp. This is the first time divergent N-glycan precursors
are seen within a single genus of Apicomplexa, suggesting
that the Alg genes are progressively lost after the emer-
gence of Cryptosporidium spp. Similarly, the enzyme in-
volved in the addition of the third mannose to the GPI
anchor core structure, mannosyltransferase, is absent from
the C. ubiquitum genome. Previously, mannosyltransfer-
ase was shown to be missing in Giardia and Entamoeba,
while all enzymes in this pathway are absent in Trichomo-
nas [31]. Recently, an absence of mannosyltransferases
was detected in Eimeria falciformis [44].
Cryptosporidium spp. differ from each other in host
specificity and tissue tropism. Presumably, the attach-
ment and invasion of host cells are determinants for
host specificity and tissue tropism, although differences
in mitosome metabolism are probably also involved in
the latter. Due to the relatively simple oral-fecal life cycle
and the epicellular position of parasitism in restricted host
cell type, the repertoire of invasion-related proteins is sig-
nificantly reduced in Cryptosporidium spp. compared with
other apicomplexans [45]. Thus far, the most obvious gen-
etic differences between C. parvum and C. hominis are in
the number of paralogous genes encoding secreted
MEDLE family proteins and insulinase-like proteases in
3’subtelomeric regions of chromosomes 5 and 6 [18]. The
role of these proteins in host specificity of Cryptosporid-
ium spp. is supported by observations in this study, as C.
ubiquitum and C. andersoni have lost altogether regions
encoding these proteins. C. andersoni has further lost
many genes of the insulinase-like proteases elsewhere in
its genome. Mucin-type glycoproteins probably also
play an important role in host specificity and tissue
tropism, as they have shown high diversity in gene
composition and sequences among Cryptosporidium
spp., especially between the intestinal and gastric
Cryptosporidium species. Other surface proteins such
as TRAPs are known to be involved in invasion, but
their role in host specificity determination is probably
limited, as all Cryptosporidium spp. largely have the
same class and number of TRAPs.
Results of this comparative genomic analysis have
revealed drastic genetic differences between gastric and
intestinal Cryptosporidium species. For example, C.
andersoni differs from C. parvum, C. hominis, and C. ubi-
quitum significantly in not only genome organizations but
also mitosome metabolism and invasion-associated
secreted proteins and peptidases. Previously, gastric and
intestinal Cryptosporidium species formed separate clades
in phylogenetic analysis of the small subunit rRNA gene
[46]. In addition to taxonomic implications, these findings
suggest that the two groups of pathogens may require dif-
ferent strategies in the development of therapeutic agents.
For example, Cryptosporidium spp. were known to use
mainly glycolysis for energy metabolism and an alternative
AOX pathway for electron transport. Based on findings
from this study, drugs targeting these pathways probably
are effective against only intestinal Cryptosporidium, as
gastric species such as C. andersoni and C. muris also use
TCA cycle for energy metabolism and have a near conven-
tional oxidative phosphorylation pathway for electron
transport. Although C. ubiquitum has genomic features
and gene content very similar to C. parvum and C. homi-
nis, it may respond to drugs differently. For example, the
absence of the AOX electron transport system in C.
ubiquitum suggests that ascofuranone, which is a well-
known AOX inhibitor in T. brucei, a protozoon relying on
the AOX pathway for electron transport [29], may not be
effective against this intestinal Cryptosporidium species.
Similarly, although the synthesis and metabolism of
isoprenoids have been targets for drug development in
apicomplexan parasites [22, 47], the absence of the apico-
plast in Cryptosporidium spp. and polyisoprenoid biosyn-
thesis in C. ubiquitum indicates that effectiveness of this
approach is probably limited against Cryptosporidium
spp., especially C. ubiquitum. Currently, there is no
specific anti-parasitic agent against Cryptosporidium spp.
The diversity in mitochondrial metabolism and invasion-
related proteins within the Cryptosporidium genus
suggests that different approaches may be needed in the
development of therapeutic agents against gastric and
intestinal Cryptosporidium spp.
Conclusions
In conclusion, we sequenced the genomes of six C.
ubiquitum and C. andersoni isolates and performed a
comparative genomics analysis of Cryptosporidium spp.
and other apicomplexans. Results of this analysis suggest
that C. ubiquitum and C. andersoni share many genomic
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features with C. parvum and C. hominis, but have diver-
gent mitosome metabolism, electron transport chains,
and invasion-related surface or secreted proteins and
peptidases. This indicates the occurrence of a progres-
sive reductive evolution in mitosome metabolism in the
Cryptosporidium lineage within Apicomplexa. Associ-
ated with this is the differential evolution of invasion-
related proteins, especially between the intestinal and
gastric groups. With improved cultivation and animal
models and development of genetic manipulation tools
in recent years [48, 49], the biologic importance of these
genetic differences among Cryptosporidium species
could be verified. This in turn may lead to the develop-
ment of intervention strategies against these important
waterborne and zoonotic pathogens in both developing
countries and industrialized nations.
Methods
Sample processing
C. ubiquitum isolates 39668, 39725, and 39726 were col-
lected from sporadic cases of human cryptosporidiosis
in Wisconsin, USA in summer, 2013, whereas C. ander-
soni isolates 30847, 31729, and 37034 were collected
from beef cattle in Alberta, Canada in 2009, dairy cattle
in Henan, China in 2010, and water buffalo in Kafr El
Sheikh, Egypt in 2011, respectively. They were diagnosed
to Cryptosporidium species by PCR-RFLP analysis and
DNA sequencing of the small subunit rRNA gene [46].
C. ubiquitum was further subtyped by DNA sequence
analysis of the gp60 gene [12]. Among the three C.
ubiquitum isolates, 39668 and 39726 belonged to the
XIIb subtype family whereas 39725 belonged to the XIIc
subtype family. Cryptosporidium oocysts were purified
from the specimens using a combination of sucrose and
cesium chloride gradient centrifugation and immuno-
magnetic separation [50]. Total genomic DNA was ex-
tracted from purified oocysts using the QIAamp®DNA
Mini Kit (Qiagen Sciences, Germantown, Maryland),
after the oocysts were subjected to five freeze-thaw cy-
cles and overnight digestion with proteinase K. Extracted
DNA was amplified using REPLI-g Midi Kit (Qiagen).
Genome sequencing and assembly
Genomes of C. ubiquitum and C. andersoni were se-
quenced on an Illumina Genome Analyzer IIX using the
Illumina TruSeq (v3) library protocol, with 100 × 100 bp
paired-end reads generated. Sequence reads with quality
score below 30 were trimmed using CLC Genomics
Workbench 7.03 (http://www.clcbio.com/products/clc-
genomics-workbench). Using the same software, they
were assembled de novo into contigs with word size of
40, bubble size of 50, and minimum contig length of
500 bp. Assemblies of C. ubiquitum isolate 39726 and C.
andersoni isolate 30847 were selected for gene prediction,
genome annotation and comparative genomics analysis.
Analysis of genome structure
After the de novo assembly of sequencing reads, Mauve
2.3.1 [51] and MUMmer 3.2.3 [52] were used to map C.
ubiquitum contigs to the published C. parvum IOWA
genome [5] and C. andersoni contigs to the published C.
muris RN66 genome (CryptoDB) using default parame-
ters. Unmapped contigs represented C. ubiquitum- or C.
andersoni-unique ones or those from contaminating
microbes. BLASTN [53] analysis of GenBank nucleotides
database was used to identify contigs from contaminants
using e-value threshold as 1e-10. The syntenic relation-
ship between the C. ubiquitum or C. andersoni genome
and C. parvum genome was visualized by using Circos
0.67 [54], with sequence identities of >75% shown.
Software packages tRNAscan-SE 1.3.1 [55] and ARA-
GORN 1.2.36 [56] were used to identify tRNAs. Both of
them were executed at the default settings using the gen-
eral tRNA model or standard genetic codon. Ribosomal
RNA genes were predicted using RNAmmer 1.2 [57] and
BLASTN. Other genomic features such as mean length,
N50 and N90 of contigs and GC content were calculated.
Gene prediction
Protein-coding genes were predicted using a pipeline of
three software packages, including AUGUSTUS 2.7 [58],
SNAP [59], and GeneMark-ES [60]. All three software
packages were run suing the default settings. Prior to
their use in gene prediction, AUGUSTUS and SNAP
were trained with the gene model of the published C.
parvum IOWA genome (CryptoDB release-6.0) for the
prediction of C. ubiquitum genes, and gene model of the
published C. muris RN66 genome (CryptoDB release-
6.0) for the prediction of C. andersoni genes. The length
and identities of gene sequences predicted by the three
approaches were compared with the reference genomes.
As the outcome from AUGUSTUS agreed mostly with
the reference genomes, the gene set predicted by AU-
GUSTUS was supplemented with new genes predicted
by GeneMark-ES and SNAP. Only genes predicted by
both software package were added to the proteome pre-
dicted by AUGUSTUS.
The frequency of protein translation codon usage for
each genome was calculated using INCA 2.1 [61]. The
entire coding region and 500 bp upstream were ex-
tracted to search the most conserved or overrepresented
motifs in each genome by using MEME 4.9 [62] with the
width threshold as 6-8 bp. SignalP 4.1 [63] and
TMHMM 2.0 [64] were used to identify signal peptides
and the transmembrane domains in predicted proteins,
respectively. Proteins with GPI anchor sites were identi-
fied by using the GPI-SOM webserver [65]. The mucin-
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type O-glycoproteins were predicted by using NetOGlyc
3.1 [66]. These software packages were run using the
default parameters.
Functional annotation and comparative genomics analysis
proteins
The predicted proteomes of C. ubiquitum and C. ander-
soni were compared with those of other Cryptosporid-
ium spp. using OrthoMCL [67], BLASTP [53] and in-
house scripts to identify shared orthologs and potential
species-unique proteins in each genome. OrthoMCL and
BLASTP were run with e-value thresholds of 1e-1 and
1e-3, respectively. The in-house scripts were used to
extract synthenic genes located in the genome but not
identified by OrthoMCL or BLASTP. The genes located
in the non-syntenic regions were considered as potential
species-unique protein-encoding genes. Protein domains in
them were identified using Pfam (http://pfam.xfam.org/)
with the default setting [68].
Comparative metabolism analyses of C. ubiquitum and
C. andersoni were performed using the web server
KAAS [69] with the BBH (Bi-directional Best Hit)
method and eukaryote gene model. BLASTP search of
the GenBank NR database was used as a supplemental
analysis. Data on metabolic pathways, catalytic enzymes,
and functional proteins of other apicomplexans were re-
trieved primarily from online databases LAMP (Library
of Apicomplexan Metabolic Pathways, release-2) [21],
KEGG (http://www.genome.jp/kegg/), and Pfam [68],
with the EuPathDB (http://eupathdb.org/eupathdb/) as
the supplement. Comparisons of transporter proteins
and invasion-related proteins among Cryptosporidium
species were mainly based on Pfam search results.
Phylogenetic analysis
A venn diagram of shared orthologs and species-specific
genes of C. parvum, C. hominis, C. ubiquitum and C.
andersoni was drawn using the web-tool Venny (http://
bioinfogp.cnb.csic.es/tools/venny/). The amino acids
sequences of 100 orthologs shared by C. ubiquitum, C.
andersoni and other common apicomplexan parasites,
including C. parvum, C. hominis, Eimeria tenella, Neos-
pora caninum, T. gondii, P. falciparum, P. vivax, Babesia
bovis, Theileria annulata, and T. parva, were extracted
to construct a neighbor-joining tree with the maximum
composite likelihood mode for distance calculation and
1000 replications for bootstrapping. The concatenated
amino acid sequences were aligned with ClustalX [70],
trimmed off un-aligned region using Gblocks [71], and
used in MEGA 6 [72] for the construction of the
neighbor-joining tree. A concatenated sequence from
the free-living photosynthetic chromerid, Chromera
velia, was used to root the tree.
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